Use of oseltamivir antiviral drugs as a first line of defense against avian influenza is one of the key recommendations made by the World Health Organization in its updated avian influenza A(H5N1) virus infection guidelines. The WHO also calls for standardized care and prompt sharing of clinical information in cases of avian flu.

Related Summaries